Canopus Medical AB is contracted by ZymIQ Technology AB Canopus Medical AB, a Swedish medical device and cosmetics development and manufacturing company, today announced that it has contracted the Swedish life science company ZymIQ Technology AB for the manufacturing of ZymIQ´s core products DentaPrev, Kalzyme K9, and fjör. Canopus Medical will care for the complete […]
Press Release: Lund – Sweden, October 14, 2022 Read More »
Canopus Medical AB has contracted OPERA CRO to conduct its clinical trials in Europe Canopus Medical AB today announced that the company has entered an agreement for clinical services with the global contract research organization (CRO) OPERA, for the planning and execution of its clinical studies. The studies will cover all three dermal filler products
Press Release: Lund, Sweden – October 6, 2022 Read More »
Canopus Medical AB is contracted by XLASH to produce its high-quality eyelash serum products. Canopus Medical AB, a Swedish skincare development and manufacturing company, today announced that it is has completed a contract manufacturing agreement for the development and manufacturing of the high-quality eyelash serum by XLASH, a leading cosmetic company based in Stockholm, Sweden.
Press Release: Lund, Sweden – May 12, 2022 Read More »
Canopus Medical AB and Hyamedix ApS (Copenhagen) signed today a licensing agreement to develop a new product for treatment of Osteoarthritis (OA). A unique hydrogel formulation will be developed by Hyamedix and Canopus to target the growing need for single injection products for treatment of OA, a very common form of arthritis, affecting millions of
Press Release: Lund, July 22, 2020 Read More »
Canopus Medical AB, the skin care development company, today announced that in support of customer requirements for increasing sales to key markets globally, it has successfully achieved certification by the International Organization for Standardization’s (ISO) highest Cosmetic standard – 22716 for Good Manufacturing Standards (GMP). This certification of the production facility, granted on June 17, 2020,
